GordonMD Global Investments

GordonMD Global Investments is an alternative investment firm dedicated to identifying and sourcing highly differentiated opportunities within the biopharmaceutical and broader healthcare sectors. The firm employs a deep expertise in medical and scientific analysis combined with extensive investment experience to uncover unique investment theses, focusing on areas often overlooked by generalist funds. This approach allows for a highly specialized evaluation of complex scientific and market landscapes.

The firm was founded in June 2021 by Dr. Craig Gordon, who serves as CEO and CIO. Dr. Gordon, a licensed physician with over a decade of prior buy-side investment experience, established GordonMD Global Investments based on the insight that a blend of specialized medical knowledge and financial acumen could unlock superior value in the rapidly evolving biopharmaceutical space. His background provides a distinct advantage in navigating the scientific intricacies and market dynamics of healthcare investments.

GordonMD Global Investments primarily serves institutional investors and sophisticated limited partners seeking exposure to high-conviction, specialized investments. The firm's vision centers on becoming a premier partner for capital deployment into disruptive and innovative companies that are poised to reshape the future of medicine and patient care, driving both financial returns and meaningful impact in critical health areas.